Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
630
-
Total 13F shares, excl. options
-
71.4M
-
Shares change
-
-1.2M
-
Total reported value, excl. options
-
$26.8B
-
Value change
-
-$490M
-
Put/Call ratio
-
0.95
-
Number of buys
-
290
-
Number of sells
-
-270
-
Price
-
$375.96
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q4 2017
752 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2017.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 630 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71.4M shares
of 105M outstanding shares and own 68.01% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.01M shares), FMR LLC (5.63M shares), Vanguard Group Inc (5.49M shares), Capital World Investors (4.81M shares), WELLINGTON MANAGEMENT GROUP LLP (4.33M shares), STATE STREET CORP (3.32M shares), SANDS CAPITAL MANAGEMENT, LLC (2.56M shares), LOOMIS SAYLES & CO L P (2.1M shares), JANUS HENDERSON GROUP PLC (1.67M shares), and POLEN CAPITAL MANAGEMENT LLC (1.39M shares).
This table shows the top 630 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.